Skip to main content
Equibles

MORGAN STANLEY

Position in NVCT — Nuvectis Pharma, Inc.

CIK 895421 NEW YORK, NY
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$344,276
+$169,827 QoQ
Shares Held
18,721
-17.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 82 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NVCT ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NVCT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $344,276 18,721
2026-03-31 $174,449 22,568
2025-12-31 $211,481 28,011
2025-09-30 $111,471 18,517
2025-06-30 $184,456 24,693
2025-03-31 $68,164 6,977
2024-12-31 $12,545 2,319
2024-09-30 $14,768 2,348
2024-06-30 $64,552 10,198
2024-03-31 $337,764 41,191
2023-12-31 $191,110 22,915
2023-09-30 $44,843 3,479
2023-06-30 $81,493 5,103
2023-03-31 $40,836 3,115
2022-12-31 $2,257 301
2022-09-30 $1,425 201
2022-06-30 $2,240 200